Volume reductions in frontopolar and left perisylvian cortices in methamphetamine induced psychosis

Schizophrenia Research

Volumn 147, Issue 2-3, 2013, Pages 355-361

  Aoki, Yuta ^a,b   Orikabe, Lina ^a   Takayanagi, Yoichiro ^b   Yahata, Noriaki ^a   Mozue, Yuriko ^b   Sudo, Yasuhiko ^b   Ishii, Tatsuji ^b   Itokawa, Masanari ^c   Suzuki, Michio ^d   Kurachi, Masayoshi ^d   Okazaki, Yuji ^b   Kasai, Kiyoto ^a   Yamasue, Hidenori ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Brain; Brodmann area (BA) 10; Frontal pole; Human; Stimulant; Substance use

Indexed keywords

METHAMPHETAMINE;

ADULT; ANTERIOR SUPERIOR TEMPORAL GYRUS; ANTISOCIAL BEHAVIOR; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; FRONTOPOLAR CORTEX; GRAY MATTER; HUMAN; INFERIOR FRONTAL GYRUS; MALE; METHAMPHETAMINE ASSOCIATED PSYCHOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PATHOPHYSIOLOGY; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; SUPERIOR TEMPORAL GYRUS; SUPRASYLVIAN GYRUS; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADULT; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; FRONTAL LOBE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; METHAMPHETAMINE; PSYCHOTIC DISORDERS; TEMPORAL LOBE; YOUNG ADULT;

EID: 84878993897     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.04.029     Document Type: Article

References (68)

1. Anderson S.W., Bechara A., Damasio H., Tranel D., Damasio A.R. Impairment of social and moral behavior related to early damage in human prefrontal cortex. Nat. Neurosci. 1999, 2:1032-1037.
2. Anggard E., Jonsson L.E., Hogmark A.L., Eng C., Gunne L.M. Amphetamine metabolism in amphetamine psychosis. Clin. Pharmacol. Ther. 1973, 14:870-880.
3. Asami T., Bouix S., Whitford T.J., Shenton M.E., Salisbury D.F., McCarley R.W. Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation. NeuroImage 2012, 59:986-996.
4. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007, 38:95-113.
5. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. NeuroImage 2000, 11:805-821.
6. Bartzokis G. Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology 2012, 62:2137-2153.
7. Bartzokis G., Lu P.H., Stewart S.B., Oluwadara B., Lucas A.J., Pantages J., Pratt E., Sherin J.E., Altshuler L.L., Mintz J., Gitlin M.J., Subotnik K.L., Nuechterlein K.H. In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr. Res. 2009, 113:322-331.
8. Bora E., Fornito A., Radua J., Walterfang M., Seal M., Wood S.J., Yücel M., Velakoulis D., Pantelis C. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr. Res. 2011, 127:46-57.
9. Callaghan R.C., Cunningham J.K., Allebeck P., Arenovich T., Sajeev G., Remington G., Boileau I., Kish S.J. Methamphetamine use and schizophrenia: a population-based cohort study in California. Am. J. Psychiatry 2012, 169:389-396.
10. Chan R.C.K., Di X., McAlonan G.M., Gong Q.-Y. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr. Bull. 2011, 37:177-188.
11. Chase H.W., Eickhoff S.B., Laird A.R., Hogarth L. The neural basis of drug stimulus processing and craving: an activation likelihood estimation meta-analysis. Biol. Psychiatry 2011, 70:785-793.
12. Ellinwood E.H. Amphetamine psychosis: II. Theoretical implication. Int. J. Neuropsychiatry 1968, 4:45-54.
13. Ellinwood E.H., Sudilovsky A., Nelson L.M. Evolving behavior in the clinical and experimental amphetamine model psychosis. Am. J. Psychiatry 1973, 130:1088-1093.
14. Flaum M., Schultz S.K. When does amphetamine-induced psychosis become schizophrenia?. Am. J. Psychiatry 1996, 153:812-815.
15. Fusar-Poli P., Radua J., McGuire P., Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr. Bull. 2012, 38:1297-1307.
16. Girgis R.R., Diwadkar V.A., Nutche J.J., Sweeney J.A., Keshavan M.S., Hardan A.Y. Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study. Schizophr. Res. 2006, 82:89-94.
17. Glahn D.C., Laird A.R., Ellison-Wright I., Thelen S.M., Robinson J.L., Lancaster J.L., Bullmore E., Fox P.T. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol. Psychiatry 2008, 64:774-781.
18. Glasser M.F., Van Essen D.C. Mapping human cortical areas in vivo based on myelin content as revealed by t1- and t2-weighted MRI. J. Neurosci. 2011, 31:1597-1616.
19. Grant K.M., LeVan T.D., Wells S.M., Li M., Stoltenberg S.F., Gendelman H.E., Carlo G., Bevins R.A. Methamphetamine-associated psychosis. J. Neuroimmune Pharmacol. 2012, 7:113-139.
20. Greene J.D., Sommerville R.B., Nystrom L.E., Darley J.M., Cohen J.D. An fMRI investigation of emotional engagement in moral judgment. Science 2001, 293:2105-2108.
21. Grelotti D.J., Kanayama G., Pope H.G. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am. J. Psychiatry 2010, 167:17-23.
22. Heitmiller D.R., Nopoulos P.C., Andreasen N.C. Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent. Schizophr. Res. 2004, 66:137-142.
23. Hirayasu Y., Shenton M.E., Salisbury D.F., Dickey C.C., Fischer I.A., Mazzoni P., Kisler T., Arakaki H., Kwon J.S., Anderson J.E., Yurgelun-Todd D., Tohen M., McCarley R.W. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am. J. Psychiatry 1998, 155:1384-1391.
24. Hollingshead A.d.B. Two Factor Index of Social Position 1957, Yale University, Dept. of Sociology, New Haven, Conn.
25. Iwanami A., Kato N., Nakatani Y. P300 in methamphetamine psychosis. Biol. Psychiatry 1991, 30:726-730.
26. Iwashiro N., Suga M., Takano Y., Inoue H., Natsubori T., Satomura Y., Koike S., Yahata N., Murakami M., Katsura M., Gonoi W., Sasaki H., Takao H., Abe O., Kasai K., Yamasue H. Localized gray matter volume reductions in the pars triangularis of the inferior frontal gyrus in individuals at clinical high-risk for psychosis and first episode for schizophrenia. Schizophr. Res. 2012, 137:124-131.
27. Jönsson L.E., Lewander T., Gunne L.M. Amphetamine psychosis: urinary excretion of catecholamines and concentrations of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid. Res. Commun. Chem. Pathol. Pharmacol. 1971, 2:355-369.
28. Kasai K., Shenton M.E., Salisbury D.F., Hirayasu Y., Onitsuka T., Spencer M.H., Yurgelun-Todd D.A., Kikinis R., Jolesz F.A., McCarley R.W. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 2003, 60:766-775.
29. Kim S.J., Lyoo I.K., Hwang J., Chung A., Hoon Sung Y., Kim J., Kwon D.-H., Chang K.H., Renshaw P.F. Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int. J. Neuropsychopharmacol. 2006, 9:221-228.
30. Kishimoto M., Ujike H., Motohashi Y., Tanaka Y., Okahisa Y., Kotaka T., Harano M., Inada T., Yamada M., Komiyama T., Hori T., Sekine Y., Iwata N., Sora I., Iyo M., Ozaki N., Kuroda S. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol. Psychiatry 2008, 63:191-196.
31. Koob G.F. Drug addiction: the yin and yang of hedonic homeostasis. Neuron 1996, 16:893-896.
32. Laakso M.P., Gunning-Dixon F., Vaurio O., Repo-Tiihonen E., Soininen H., Tiihonen J. Prefrontal volumes in habitually violent subjects with antisocial personality disorder and type 2 alcoholism. Psychiatry Res. 2002, 114:95-102.
33. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., Keefe R.S., Green A.I., Gur R.E., McEvoy J., Perkins D., Hamer R.M., Gu H., Tohen M., HGDH Study Group Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 2005, 62:61-70.
34. Lucantonio F., Stalnaker T.A., Shaham Y., Niv Y., Schoenbaum G. The impact of orbitofrontal dysfunction on cocaine addiction. Nat. Neurosci. 2012, 15:358-366.
35. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 2003, 19:1233-1239.
36. Matsuoka K., Uno M., Kasai K., Koyama K., Kim Y. Estimation of premorbid IQ in individuals with Alzheimer's disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test. Psychiatry Clin. Neurosci. 2006, 60:332-339.
37. Matsuzawa D., Hashimoto K., Miyatake R., Shirayama Y., Shimizu E., Maeda K., Suzuki Y., Mashimo Y., Sekine Y., Inada T., Ozaki N., Iwata N., Harano M., Komiyama T., Yamada M., Sora I., Ujike H., Hata A., Sawa A., Iyo M. Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. Am. J. Psychiatry 2007, 164:1105-1114.
38. McCarley R.W., Salisbury D.F., Hirayasu Y., Yurgelun-Todd D.A., Tohen M., Zarate C., Kikinis R., Jolesz F.A., Shenton M.E. Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Arch. Gen. Psychiatry 2002, 59:321-331.
39. McKetin R., McLaren J., Lubman D.I., Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006, 101:1473-1478.
40. Modinos G., Costafreda S.G., van Tol M.-J., McGuire P.K., Aleman A., Allen P. Neuroanatomy of auditory verbal hallucinations in schizophrenia: a quantitative meta-analysis of voxel-based morphometry studies. Cortex 2013, 49:1046-1055.
41. Molina V., Galindo G., Cortés B., de Herrera A.G.S., Ledo A., Sanz J., Montes C., Hernández-Tamames J.A. Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261:313-322.
42. Moll J., Krueger F., Zahn R., Pardini M., de Oliveira-Souza R., Grafman J. Human fronto-mesolimbic networks guide decisions about charitable donation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15623-15628.
43. Morales A.M., Lee B., Hellemann G., O'Neill J., London E.D. Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend. 2012, 125:230-238.
44. Müller J.L., Gänßbauer S., Sommer M., Döhnel K., Weber T., Schmidt-Wilcke T., Hajak G. Gray matter changes in right superior temporal gyrus in criminal psychopaths. Evidence from voxel-based morphometry. Psychiatry Res. 2008, 163:213-222.
45. Navari S., Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol. Med. 2009, 39:1763-1777.
46. Nelson H.E. National Adult Reading Test (NART) 1982, NFER-Nelson, Windsor, UK.
47. Nopoulos P.C., Ceilley J.W., Gailis E.A., Andreasen N.C. An MRI study of midbrain morphology in patients with schizophrenia: relationship to psychosis, neuroleptics, and cerebellar neural circuitry. Biol. Psychiatry 2001, 49:13-19.
48. Orikabe L., Yamasue H., Inoue H., Takayanagi Y., Mozue Y., Sudo Y., Ishii T., Itokawa M., Suzuki M., Kurachi M., Okazaki Y., Kasai K. Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis. Schizophr. Res. 2011, 132:183-189.
49. Overall J.E., Donald R.G. The brief psychiatric rating scale. Psychol. Rep. 1962, 10:799-812.
50. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., McGuire P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361:281-288.
51. Raine A., Lencz T., Bihrle S., LaCasse L., Colletti P. Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch. Gen. Psychiatry 2000, 57:119-128.
52. Rounsaville B.J. DSM-V research agenda: substance abuse/psychosis comorbidity. Schizophr. Bull. 2007, 33:947-952.
53. Rylander G. Psychoses and the pudding and choreiform syndromes in addiction to central stimulant drug. Psychiatr. Neurol. Neurochir. 1972, 75:203-212.
54. Sato M., Numachi Y., Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr. Bull. 1992, 18:115-122.
55. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., Takei N., Mori N. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am. J. Psychiatry 2001, 158:1206-1214.
56. Sekine Y., Minabe Y., Ouchi Y., Takei N., Iyo M., Nakamura K., Suzuki K., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., Mori N. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am. J. Psychiatry 2003, 160:1699-1701.
57. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
58. Substance Abuse and Mental Health Services Administration office of applied studies Results from the 2007 National Survey on Drug Use and Health 2012.
59. Suga M., Yamasue H., Abe O., Yamasaki S., Yamada H., Inoue H., Takei K., Aoki S., Kasai K. Reduced gray matter volume of Brodmann's Area 45 is associated with severe psychotic symptoms in patients with schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2010, 260:465-473.
60. Takahashi T., Suzuki M., Zhou S.-Y., Tanino R., Nakamura K., Kawasaki Y., Seto H., Kurachi M. A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia. Schizophr. Res. 2010, 119:65-74.
61. Takayanagi Y., Kawasaki Y., Nakamura K., Takahashi T., Orikabe L., Toyoda E., Mozue Y., Sato Y., Itokawa M., Yamasue H., Kasai K., Kurachi M., Okazaki Y., Matsushita M., Suzuki M. Differentiation of first-episode schizophrenia patients from healthy controls using ROI-based multiple structural brain variables. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:10-17.
62. Tsujimoto S., Genovesio A., Wise S.P. Frontal pole cortex: encoding ends at the end of the endbrain. Trends Cogn. Sci. 2011, 15:169-176.
63. Verhoeff N.P., Meyer J.H., Kecojevic A., Hussey D., Lewis R., Tauscher J., Zipursky R.B., Kapur S. A voxel-by-voxel analysis of [18F] setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia. Psychiatry Res. 2000, 99:123-135.
64. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders, Diagnostic Criteria for Research 1993.
65. Yamasue H., Iwanami A., Hirayasu Y., Yamada H., Abe O., Kuroki N., Fukuda R., Tsujii K., Aoki S., Ohtomo K., Kato N., Kasai K. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Psychiatry Res. 2004, 131:195-207.
66. Yamasue H., Suga M., Yahata N., Inoue H., Tochigi M., Abe O., Liu X., Kawamura Y., Rogers M.A., Takei K. Reply to: Neurogenetic effects of OXTR rs2254298 in the extended limbic system of healthy Caucasian adults. Biol. Psychiatry 2011, 70:e41-e42.
67. Yang Y., Raine A., Colletti P., Toga A.W., Narr K.L. Abnormal temporal and prefrontal cortical gray matter thinning in psychopaths. Mol. Psychiatry 2009, 14:561-562. (555).
68. Yoshida T., McCarley R.W., Nakamura M., Lee K., Koo M.-S., Bouix S., Salisbury D.F., Morra L., Shenton M.E., Niznikiewicz M.A. A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr. Res. 2009, 113:84-94.